Hospitals to get £2.6m for infrastructure upgrades
Several hospitals are set to get upgrades after Nottinghamshire Healthcare NHS Foundation Trust has secured government funding.
Work will include improving fire safety systems, water infrastructure and electrical and energy systems at Rampton Hospital, The Wells Road Centre, Wathwood Hospital, Thorneywood Mount and Arnold Lodge Hospital.
The improvements at the sites, which offer mental health and community services across the Midlands and South Yorkshire, are due to start in the summer with the aim of completing next spring.
Nottinghamshire Healthcare NHS Foundation Trust, which runs the hospitals, said the funding would support urgent projects and create a better environment for patients.
The £2,595,000 grant is part of a national project to improve NHS buildings and infrastructure in England.
At Rampton High Secure Hospital and several others, it is hoped the money will allow a full upgrade of fire safety systems - including alarms, fire compartmentation and suppression technology.
The Wells Road Centre in Mapperley, Nottingham, will benefit from the replacement of ageing machinery.
While at Arnold Lodge, in Leicester, a specialist secure unit, the money will deliver electrical and energy system improvements.
The trust said planning work was under way to ensure the disruption was minimal.
Chief executive at the trust Ifti Majid said the funding was "fantastic news", adding: "It allows us to fast-track improvements that make our hospitals safer, greener and more welcoming places to receive care and to work."
Alison Wyld, executive director of finance and estates, added: "By tackling our highest-risk infrastructure now, we're not only reducing future maintenance costs but also supporting the trust's net zero ambitions."
Follow BBC Nottingham on Facebook, on X, or on Instagram. Send your story ideas to eastmidsnews@bbc.co.uk or via WhatsApp on 0808 100 2210.
High-security hospital 'still needs to improve'
Work begins on £12m endoscopy unit at city hospital
Construction under way on new hospital theatre suite
Photos show 'crumbling', abandoned hospital rooms
Nottinghamshire Healthcare NHS Foundation Trust
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
ADHD drugs back in the spotlight after study debunks rising prevalence
An increasing number of patients are seeking support for attention-deficit/hyperactivity disorder (ADHD), with pharmacological-based treatments an important part of medical care for the neurodevelopmental condition. A study published this week in the Journal of Affective Disorders has found that greater awareness and acceptance around the disorder has led to more people seeking help. The research, led by a team at King's College, London, debunks claims that the disorder is 'naturally' on the rise. The data comes as a national taskforce in England investigates what this rising demand for support means for the NHS. Figures published in May 2025 by NHS England estimated there were nearly 2.5 million people in England with ADHD. This includes more than 550,000 currently waiting for an assessment. Every month 20,000 more people are referred for support, a rise of 13% compared to last year. Pharmaceutical Technology looks at some of the current options in the UK and casts an eye ahead to what the future drug landscape might contain. The first choice for patients with ADHD is methylphenidate, which belongs to a class of drugs called central nervous system (CNS) stimulants. The drug, which works by blocking the reuptake of norepinephrine and dopamine, increases activity in the brain, including regions associated with attention and behaviour. It is known under the brand names Ritalin, manufactured by Novartis, and Johnson and Johnson's Concerta. There is also Equasym and Xenidate, among others. Lisdexamfetamine dimesylate is also used to treat patients with ADHD. Like methylphenidate, lisdexamfetamine is a CNS stimulant and acts as a norepinephrine and dopamine reuptake inhibitor (NDRI). This drug is known under the brand name, among others, as Elvanse and Vyvanse, both manufactured by Takeda. While stimulants are fast acting, with side effects felt soon after administration, non-stimulant drugs take longer, yet can offer an alternative if drugs like methylphenidate and lisdexamfetamine dimesylate do not work. While improving, access to pharmacological-based treatments is still impaired amid an ongoing global shortage that began in September 2023. Methylphenidate and lisdexamfetamine were primarily affected – the shortage arising due to a combination of manufacturing issues and increased global demand. A separate study published in The American Journal of Managed Care in March suggested that overdiagnosis of ADHD is fuelling the shortage of stimulation medications. One of the most advanced candidate drugs, and one with notable buzz surrounding it, is Axsome's Sunosi (solriamfetol). Sunosi, which is also an NDRI but not a conventional stimulant, met its primary endpoint in a Phase III trial (NCT05972044) earlier this year. The medication led to a 45% drop in ADHD symptoms. As measured by the Adult ADHD Investigator Symptom Rating Scale (AISRS), 150mg Sunosi dosed achieved average reductions from baseline of 17.7 points, compared to 14.3 points for placebo. Sunosi is already approved in the UK to treat excessive daytime sleepiness (EDS) in adults with narcolepsy, with or without cataplexy. Certain patients with obstructive sleep apnoea (OSA) are also eligible to take the medication. In 2022, Axsome paid $53m up front to acquire Sunosi from Jazz Pharmaceuticals. A drug with a recent approval extension in the US, though not the UK, was Supernus Pharmaceuticals' Qelbree (viloxazine extended-release capsules). The mechanism of action of Qelbree, though unclear, is thought to be through inhibiting the reuptake of norepinephrine. Originally approved for children in 2021, the FDA updated the drug's label in January this year to include adults. ADHD treatments were in the political crosshairs in the US recently. The disorder, along with autism, was singled out by the Trump administration for an 'over-utilisation of medication'. Pharmaceutical intervention remains a helpful part of managing the disorder, though it is part of a combination of treatments that also include coaching and lifestyle changes. "ADHD drugs back in the spotlight after study debunks rising prevalence" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Patient records go digital to 'co-ordinate care'
All patient records at a hospital are to go digital as part of a major step "in modernising patient care". The new Electronic Patient Record (EPR) will be switched on at Northampton General Hospital (NGH) from Saturday 28 June. It has been developed by the software system Nervecentre, and is designed to bring all patient notes and information into "one single, secure digital format". William Monaghan, from NGH, described it as a "pivotal moment" and said he hoped it would mean "safer and more co-ordinated care". A hospital spokesperson said the electronic system would "enable clinical teams to access real-time information about a patient's care, helping them make quicker, safer and better-informed decisions". Patient records are currently stored in a combination of paper files and digital systems, but will be replaced by "a central, streamlined platform that enhances efficiency and reduces duplication". Mr Monaghan, group chief digital information officer, said: "This is a pivotal moment for NGH and our patients. "The new EPR system puts essential information at our clinical teams' fingertips, helping them deliver safer, more co-ordinated care. "While there may be a few teething problems as we go live, this investment in digital infrastructure will transform how we work, giving our teams more time to focus on what matters most: caring for patients." The hospital said staff would be using secure, hospital-owned mobile devices, like tablets and iPhones, at patients' bedsides. It means staff will be able to view the latest medical information instantly, spend less time on administration, avoid asking patients to repeat their history many times - and improve co-ordination between departments and services. All patient information will be kept secure, it confirmed. Follow Northamptonshire news on BBC Sounds, Facebook, Instagram and X. Hospital's A&E told to make urgent improvements Hospital staff invited to resign to reduce workforce Hospital ward is 'safe' despite concern over falls Northampton General Hospital
Yahoo
3 hours ago
- Yahoo
Hospitals to get £2.6m for infrastructure upgrades
Several hospitals are set to get upgrades after Nottinghamshire Healthcare NHS Foundation Trust has secured government funding. Work will include improving fire safety systems, water infrastructure and electrical and energy systems at Rampton Hospital, The Wells Road Centre, Wathwood Hospital, Thorneywood Mount and Arnold Lodge Hospital. The improvements at the sites, which offer mental health and community services across the Midlands and South Yorkshire, are due to start in the summer with the aim of completing next spring. Nottinghamshire Healthcare NHS Foundation Trust, which runs the hospitals, said the funding would support urgent projects and create a better environment for patients. The £2,595,000 grant is part of a national project to improve NHS buildings and infrastructure in England. At Rampton High Secure Hospital and several others, it is hoped the money will allow a full upgrade of fire safety systems - including alarms, fire compartmentation and suppression technology. The Wells Road Centre in Mapperley, Nottingham, will benefit from the replacement of ageing machinery. While at Arnold Lodge, in Leicester, a specialist secure unit, the money will deliver electrical and energy system improvements. The trust said planning work was under way to ensure the disruption was minimal. Chief executive at the trust Ifti Majid said the funding was "fantastic news", adding: "It allows us to fast-track improvements that make our hospitals safer, greener and more welcoming places to receive care and to work." Alison Wyld, executive director of finance and estates, added: "By tackling our highest-risk infrastructure now, we're not only reducing future maintenance costs but also supporting the trust's net zero ambitions." Follow BBC Nottingham on Facebook, on X, or on Instagram. Send your story ideas to eastmidsnews@ or via WhatsApp on 0808 100 2210. High-security hospital 'still needs to improve' Work begins on £12m endoscopy unit at city hospital Construction under way on new hospital theatre suite Photos show 'crumbling', abandoned hospital rooms Nottinghamshire Healthcare NHS Foundation Trust
